We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ORIC market cap is 632.28M. The company's latest EPS is USD -1.4270 and P/E is -6.28.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -28.68M | -31.43M | -28.99M | -36.02M | -38.32M |
| Net Income | -25.48M | -28.33M | -25.01M | -31.96M | -34.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -28.57M | -74.19M | -78.87M | -91.77M | -110.78M |
| Net Income | -26.88M | -73.7M | -78.72M | -89.12M | -100.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 274.34M | 252.01M | 350.79M | 328.91M | 302.07M |
| Total Liabilities | 26.92M | 27.92M | 22.14M | 26.51M | 28.08M |
| Total Equity | 247.41M | 224.09M | 328.65M | 302.4M | 273.99M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 94.09M | 299M | 298.64M | 247.18M | 252.01M |
| Total Liabilities | 6.12M | 9.22M | 25.67M | 24.83M | 27.92M |
| Total Equity | -90.08M | 289.78M | 272.98M | 222.35M | 224.09M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -61.42M | -85.69M | -30.19M | -55.81M | -84.61M |
| Investing | -64.37M | -43.4M | -61.87M | -43.59M | -20.52M |
| Financing | 85.21M | 85.66M | 125.03M | 125.85M | 125.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.53M | -45.27M | -59.54M | -75.14M | -85.69M |
| Investing | -768k | -215.96M | 158.44M | -109.25M | -43.4M |
| Financing | 70.82M | 250.51M | 49.13M | 25.23M | 85.66M |
| Market Cap | 632.28M |
| Price to Earnings Ratio | -6.28 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 27.04 |
| Price to Book Ratio | 2.82 |
| Dividend Yield | - |
| Shares Outstanding | 70.57M |
| Average Volume (1 week) | 210.07k |
| Average Volume (1 Month) | 334.79k |
| 52 Week Change | 3.82% |
| 52 Week High | 16.65 |
| 52 Week Low | 6.33 |
| Spread (Intraday) | 7.01 (66.13%) |
| Company Name | Oric Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.oricpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
